完善患者分层和治疗决策在急性SMA闭塞中
Yingjian Ye1,2, Yan Hu1,3, Xianqun Ji1,2
1Department of Emergency Surgery, Radiology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, 441000, Hubei, China.
World journal of emergency surgery : WJES
|October 15, 2025
概括
管理急性上层中枢动脉 (SMA) 阻塞需要个性化护理. 基线疾病的严重程度,而不是治疗类型 (内血管或手术),决定了患者在SMA闭塞管理中的结果.
科学领域:
- 血管外科 血管外科
- 干预性放射学 干预性放射学
- 胃肠病学 胃肠病学
背景情况:
- 急性上层中枢动脉 (SMA) 阻塞是一种具有高死亡率的危险状况.
- 最佳管理策略,比较内血管和外科重血管化,仍在争论中.
研究的目的:
- 为了比较急性SMA闭塞患者的内血管和外科再血管化的结果.
- 为了确定影响死亡率和治疗疗效的因素,在急性SMA封闭.
主要方法:
- 关于AMESI项目的未来跨国副研究.
- 血管内和外科重血管化技术的比较.
- 对基线疾病严重性标志物 (乳酸盐,机械通风) 和死亡率的分析.
主要成果:
- 根据乳酸水平和通风需求指出的基线疾病严重程度是主要的预后因素.
- 经过调整后的分析显示,内血管治疗和手术治疗之间没有显著的独立死亡率差异.
- 未调整的死亡率有显著差异 (2.9%内血管 vs 45.8%手术),归因于手术组的患者选择偏差.
结论:
- 患者选择偏差在SMA封闭研究中的未经调整的结果数据有显著影响.
- 考虑到病因和生理状态的个性化治疗决定对于急性SMA封闭至关重要.
- 目前的基于时间的干预模式可能无法普遍适用.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
219
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
219
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Atherosclerosis IV: Nursing Management
363
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
363
Acute Coronary Syndrome V: Nursing Management
269
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
269
Cardiopulmonary Resuscitation II: ACLS Airway Management
524
Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned...
524
Angina IV: Management
236
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
236


